Team

Staff Profiles

Allan Jones, Ph.D.

President & Chief Executive Officer

Allan Jones is President and Chief Executive Officer of the Allen Institute, an independent, nonprofit research organization dedicated to answering some of the biggest questions in bioscience and accelerating research worldwide.  The Allen Institute currently encompasses four divisions (the Allen Institute for Brain Science, the Allen Institute for Cell Science, the Allen Institute for Immunology, and The Paul G. Allen Frontiers Group) supported by a shared administration group.

Jones joined the Allen Institute for Brain Science in 2003, managing its growth and impact over its first decade. He led the launch of the Allen Institute for Cell Science in 2014, the launch of The Paul G. Allen Frontiers Group in 2016, and the launch of the Allen Institute for Immunology in 2018. He has been instrumental in helping the late Paul G. Allen realize his vision and legacy of broad impact on the field of bioscience, building a unique multidisciplinary team model of engineers, scientists and business professionals operating on an annual budget of approximately $150M.

Unprecedented in its size and data sharing capacity, the suite of Allen Institute for Brain Science tools and data, openly available to the public, has been used by tens of thousands of individuals and scientific communities worldwide. The Allen Institute for Cell Science is working to develop dynamic, visual data on cell organization and activities, all to be shared openly with the scientific community. The Paul G. Allen Frontiers Group expands and complements the reach of investments to identify and fund new ideas in bioscience across the world. The Allen Institute for Immunology is working to unravel the mysteries of the human immune system in health and disease. 

Originally from Wichita, Kansas, Jones received a B.S. in biology from Duke University and Ph.D. in genetics and developmental biology from Washington University School of Medicine. After a brief period as a post doc at the University of Pennsylvania, Jones joined Avitech Diagnostics, a small start-up company in Philadelphia. He moved to Seattle to work for Rosetta Inpharmatics, which was later acquired by Merck and Co. 

After the launch of the Allen Institute for Brain Science’s 10-year, $1B plan in 2012, Jones has acted as a key collaborator and organizer with a variety of organizations worldwide.  Jones attended both the European Union’s announcement in February 2013 of the Human Brain Project, and President Obama’s White House announcement in April 2013 of the BRAIN Initiative. His 2011 TED Talk has garnered more than a million views. Jones currently serves on several advisory boards and the Fred Hutchinson Cancer Research Center Board of Trustees, and is the former Chair of the World Economic Forum’s Global Agenda Council on Neuroscience and Behavior.